Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 146 700 KRW -0.68% Market Closed
Market Cap: ₩3T
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 136 255 KRW with a low forecast of 101 000 KRW and a high forecast of 178 500 KRW.

Lowest Forecast
Wall Street Target
101 000 KRW
-31% Downside
Average Forecast
Wall Street Target
136 255 KRW
-7% Downside
Highest Forecast
Wall Street Target
178 500 KRW
22% Upside
Lowest
Price Target
101 000 KRW
31% Downside
Average
Price Target
136 255 KRW
7% Downside
Highest
Price Target
178 500 KRW
22% Upside
ST Pharm Co Ltd Competitors:
Price Targets
AAT
American Assets Trust Inc
-1% Downside
BWXT
BWX Technologies Inc
15% Upside
N
NICE
Nice Ltd
94% Upside
AAT
American Assets Trust Inc
-1% Downside
BWXT
BWX Technologies Inc
15% Upside
N
NICE
Nice Ltd
94% Upside

Revenue
Forecast

11% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 23%.

What are analyst estimates?

Operating Income
Forecast

11% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
11% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 53%.

What are analyst estimates?

Net Income
Forecast

20% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss
20% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-20%
Average Miss

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 36%.

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ST Pharm Co Ltd's stock price target?
Price Target
136 255 KRW

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 136 255 KRW with a low forecast of 101 000 KRW and a high forecast of 178 500 KRW.

What is ST Pharm Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's revenue is 11%. The projected CAGR for the next 3 years is 23%.

What is ST Pharm Co Ltd's Operating Income forecast?
Projected CAGR
53%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 53%.

What is ST Pharm Co Ltd's Net Income forecast?
Projected CAGR
36%

For the last 10 years the compound annual growth rate for ST Pharm Co Ltd's net income is 20%. The projected CAGR for the next 3 years is 36%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 317,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.